ClexBio collaborates with Nordic Cell Therapy Group on VivoSet
The collaboration aims to advance the VivoSet platform toward GMP readiness and strengthen the CMC strategy behind its stem cell therapy pipeline, sharpening the development roadmap and de-risking execution.